QIMR learns tough lesson
17 April, 2002 by Pete YoungLeading Queensland medical research centre QIMR has discovered that swapping intellectual property for shares has its downside.
IBM, Mayo clinic team for medical database project
17 April, 2002 by Staff WritersIBM will provide the Mayo Clinic with database tools, permitting doctors at the famed hospital to compare notes with every other case the facility has on record, it announced today in a statement. Their goal is to make every doctor a research scientist.
Govt calls in expert biotech advice
17 April, 2002 by Daniella GoldbergA new council has been established to advise the Commonwealth government on priority issues in biotechnology, including R&D, international links, commercialisation, public interest and ethics.
Amrad: meeting to solve board dispute
17 April, 2002 by Tanya HollisAmrad Corporation has confirmed a general meeting will be held on May 22 to resolve a board dispute with its major shareholder, Fibre Optics.
Candida test breakthrough for Rockeby Biomed
17 April, 2002 by Melissa TrudingerClinical trials have validated the efficacy of a new test kit for diagnosis of systemic candidiasis, developed by Perth company Rockeby Biomed.
Peptech ditches CEO hunt
16 April, 2002 by Daniella GoldbergPeptech's worldwide hunt for a new CEO has been abandoned after three of the board members, including its Chairman Dr Ed Tweddell, walked out of the company last week under pressure from angry shareholders.
GTG reaches agreement with Nanogen
16 April, 2002 by Melissa TrudingerGenetic Technologies has announced a licence agreement with Nanogen, following the company's agreement last week with US company Sequenom.
UNSW launches misconduct probe
16 April, 2002 by Daniella GoldbergA senior immunologist and kidney specialist has been accused of committing serious scientific misconduct and misspending public funds from the National Health and Medical Research Council.
Centre of Excellence race: and then there were four
15 April, 2002 by Tanya HollisApplicants for the Federal government's Biotechnology Centre of Excellence were today whittled down to four.
Dr Tom Schneider: Wake up and smell the apple pie: we need the US
15 April, 2002 by Tanya HollisBarely a week goes by when an overseas business expert isn't out here telling Australian companies how it should be done.
New reactor to boost medical research: ANSTO
15 April, 2002 by Daniella GoldbergThe new nuclear reactor at Lucas Heights, in Sydney, will give Australian medical researchers access to the latest therapeutic radioisotopes, according to the head of the facility's radioisotope manufacturing arm.
Support for NSW start-ups
15 April, 2002 by Daniella GoldbergStart-up biotechnology companies in NSW are to receive support through a new $2.5 million project.
Macquarie Bank to advise on synchrotron
12 April, 2002 by Tanya HollisMacquarie Bank has been appointed as financial adviser to the Victorian government's $157 million synchrotron project.
Lawyers push for new agency to keep up with science
12 April, 2002 by Pete YoungThe Australian Law Reform Commission may recommend the Howard government create an Australian equivalent of the UK Human Genetics Commission.
Investment company seeks to invest $50 million in biotech
11 April, 2002 by Daniella GoldbergAustralian Technology Innovations Fund (ATIF), a Brisbane-based private investment company, is seeking to invest $50 million in biotechnology projects and companies.
